Having trouble accessing articles? Reset your cache.

Effient prasugrel: Phase II data

The double-blind, U.S. Phase II SWAP trial in 100 evaluable patients showed that switching to maintenance dosing with Effient plus aspirin from

Read the full 227 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE